Does randomization matter in rare disease clinical trials. [PDF]
Wied S +3 more
europepmc +1 more source
Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data. [PDF]
Sejersen T +5 more
europepmc +1 more source
Molecular Genetic Analysis of a <i>DMD</i> Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing. [PDF]
Chen Q, Zhang W, Zha L.
europepmc +1 more source
Serum biomarkers in Duchenne muscular dystrophy: a leap toward precision diagnostics. [PDF]
Matovu D.
europepmc +1 more source
From the Microscope to the Genome: A New Era in the Molecular Genetics of Epidermolysis Bullosa. [PDF]
Tsvetkova M, Dimitrova T, Yaneva G.
europepmc +1 more source
Turning premature stop codons into therapeutic opportunities. [PDF]
Williamson J, Jacków-Malinowska J.
europepmc +1 more source
Small molecule BLVRB redox inhibitor promotes megakaryocytopoiesis and stress thrombopoiesis in vivo. [PDF]
Nesbitt NM +11 more
europepmc +1 more source
A Unified Platform for Direct Alkynylation from Alcohols via Deoxygenative Metallaphotoredox Catalysis. [PDF]
Li YH, MacMillan DWC.
europepmc +1 more source
RiboScreen<sup>TM</sup> Technology Delivers Small-Molecule Ribodrugs to Convert Ribosomal Proteins into Molecular Valves for Tailored Protein Production Levels in Rare and Prevalent Disease <sup>†</sup>. [PDF]
Edobor G +21 more
europepmc +1 more source

